Filter Results:
(27)
Show Results For
- All HBS Web (27)
- Faculty Publications (18)
Show Results For
- All HBS Web (27)
- Faculty Publications (18)
Page 1 of 27
Results →
- 2018
- Working Paper
OTC Intermediaries
By: Andrea L. Eisfeldt, Bernard Herskovic, Sriram Rajan and Emil Siriwardane
Over-the-counter (OTC) markets for financial assets are dominated by a relatively small number of core intermediaries and a large number of peripheral customers. In this paper, we develop a model of trade in a core-periphery network and estimate its key structural... View Details
Keywords: OTC Markets; Intermediaries; Dealers; Credit Default Swaps; Risk Sharing; Networks; Price; Risk and Uncertainty
Eisfeldt, Andrea L., Bernard Herskovic, Sriram Rajan, and Emil Siriwardane. "OTC Intermediaries." Working Paper, August 2018.
- February 2023
- Article
OTC Intermediaries
By: Andrea L. Eisfeldt, Bernard Herskovic, Sriram Rajan and Emil Siriwardane
We study the effect of dealer exit on prices and quantities in a model of an over-the-counter (OTC) market featuring a core-periphery network with bilateral trading costs. The model is calibrated using regulatory data on the entire U.S. credit default swap (CDS) market... View Details
Keywords: OTC Markets; Intermediaries; Dealers; Credit Default Swaps; Risk Sharing; Financial Markets; Networks; Price; Risk and Uncertainty
Eisfeldt, Andrea L., Bernard Herskovic, Sriram Rajan, and Emil Siriwardane. "OTC Intermediaries." Review of Financial Studies 36, no. 2 (February 2023): 615–677.
- February 2000 (Revised June 2003)
- Case
Pepcid AC: Racing to the OTC Market
By: Charles King III, Alvin J. Silk, Ernst R. Berndt and Lisa R. Klein
Pepcid management must decide whether to risk all in a race to be first in the over-the-counter market with a new heartburn remedy. View Details
Keywords: Competitive Advantage; Product Positioning; Markets; Research; Marketing Strategy; Product Development; Decision Choices and Conditions; Pharmaceutical Industry
King, Charles, III, Alvin J. Silk, Ernst R. Berndt, and Lisa R. Klein. "Pepcid AC: Racing to the OTC Market." Harvard Business School Case 500-073, February 2000. (Revised June 2003.)
- November 2010
- Case
Lessons Learned? Brooksley Born & the OTC Derivatives Market (A)
By: Clayton S. Rose and David Lane
On May 7, 1998, the U.S. Commodity Futures Trading Commission, chaired by Brooksley Born, issued a "Concept Release" inviting public comment on the relevance and appropriateness of existing regulation of the over-the-counter (OTC) derivatives market, a market with a... View Details
Keywords: Financial Crisis; Credit Derivatives and Swaps; Governing Rules, Regulations, and Reforms; Policy; Business and Government Relations; Financial Services Industry; Public Administration Industry; District of Columbia
Rose, Clayton S., and David Lane. "Lessons Learned? Brooksley Born & the OTC Derivatives Market (A)." Harvard Business School Case 311-044, November 2010.
- November 2010
- Supplement
Lessons Learned? Brooksley Born & the OTC Derivatives Market (B)
By: Clayton S. Rose and David Lane
This (B) case provides the 2009 reflections of former SEC Chairman Arthur Levitt on CFTC Chairman Brooksley Born's 1998 efforts to consider regulating the OTC derivative market. It also provides a summary of the aspects of the 2010 Dodd-Frank Act that regulate these... View Details
Keywords: Financial Crisis; Credit Derivatives and Swaps; Governing Rules, Regulations, and Reforms; Policy; Government Legislation; Business and Government Relations; Financial Services Industry; Public Administration Industry; District of Columbia
Rose, Clayton S., and David Lane. "Lessons Learned? Brooksley Born & the OTC Derivatives Market (B)." Harvard Business School Supplement 311-070, November 2010.
- June 2003
- Teaching Note
Pepcid AC: Racing to the OTC Market (TN)
By: Charles King III, Alvin J. Silk and Ann Leamon
Teaching Note for (9-500-073). View Details
Keywords: Chemical Industry
- August 2011
- Teaching Note
Lessons Learned? Brooksley Born & the OTC Derivatives Market (TN) (A) and (B)
By: Clayton Rose and Sally Canter Ganzfried
Teaching Note for 311-044 and 311-070. View Details
- January 2017
- Supplement
Bayer AG: Bidding to Win Merck's OTC Business
By: Benjamin C. Esty, Marc Baaij and Arjen Mulder
- January 2017
- Case
Bayer AG: Bidding to Win Merck's OTC Business
By: Benjamin C. Esty, Marc Baaij and Arjen Mulder
Shortly after submitting their best and final offer to acquire Merck's Consumer Care Division (a collection of "over-the-counter" (OTC) products with sales totaling $2 billion), the Bayer M&A team was given a chance to revise their bid because another potential... View Details
Keywords: Acquisition; Bidding Strategy; Valuing Synergies; Negotiations; Corporate Strategy; Business Unit Strategy; Bidding Process; Discounted Cash Flow; Cross-border M&A; Tax Shields; Valuation; Competitive Strategy; Auctions; Bids and Bidding; Germany; United States; United Kingdom
Esty, Benjamin C., Marc Baaij, and Arjen Mulder. "Bayer AG: Bidding to Win Merck's OTC Business." Harvard Business School Case 217-021, January 2017.
- March 2006
- Case
Bringing OTC back to the Exchange: Euronext.liffe's launch of ABC
Euronex.liffe, a derivatives trading exchange, launches matching, clearing, and confirmation services for the over-the-counter market. This combination of services creates a new platform for a market that potentially cannibalizes its current exchange-based services. Is... View Details
Cantillon, Estelle S., and Pai-Ling Yin. "Bringing OTC back to the Exchange: Euronext.liffe's launch of ABC." Harvard Business School Case 706-489, March 2006.
- June 2006 (Revised September 2006)
- Case
Euronext.liffe and the Over-the-Counter Derivatives Market (A)
Euronext.liffe, a derivatives trading exchange, had just finished rolling out three new services targeted at the over-the-counter (OTC) market in 2004. The services offered automated confirmation and clearing for OTC equity derivatives. Yet, developments in the... View Details
Keywords: Value Creation; Product Positioning; Competition; Financial Markets; Network Effects; Cooperation
Cantillon, Estelle S. "Euronext.liffe and the Over-the-Counter Derivatives Market (A)." Harvard Business School Case 706-515, June 2006. (Revised September 2006.)
- Article
The Value of Trading Relations in Turbulent Times
By: Marco Di Maggio, Amir Kermani and Zhaogang Song
This paper investigates how dealers’ trading relations shape their trading behavior in the corporate bond market. Dealers charge lower spreads to dealers with whom they have the strongest ties and more so during periods of market turmoil. Systemically important dealers... View Details
Keywords: OTC Markets; Network; Corporate Bonds; Crisis; Intermediation Chains; Leaning Against The Wind; Networks; Bonds; Behavior; Financial Crisis
Di Maggio, Marco, Amir Kermani, and Zhaogang Song. "The Value of Trading Relations in Turbulent Times." Journal of Financial Economics 124, no. 2 (May 2017): 266–284.
- October 1981 (Revised June 1985)
- Case
Vicks Health Care Division: Project Scorpio (A)
The Vicks Health Care Division lacks a solid form entry in the OTC colds care category and has developed a "me-too" product. The main issues are whether there is an opportunity for the product, and, if so, how it should be positioned. Main teaching objectives are to... View Details
Keywords: Product Positioning; Health Care and Treatment; Product Launch; Market Participation; Health Industry
Yip, George S., and Jeffrey R Williams. "Vicks Health Care Division: Project Scorpio (A)." Harvard Business School Case 582-039, October 1981. (Revised June 1985.)
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
RIPPLE EFFECT “A woman gets a period around age 12 to 14, and then we tell her to go off in the world and not get pregnant.” “A woman gets a period around age 12 to 14, and then we tell her to go off in the world and not get pregnant.” For 15 years, the morning-after... View Details
- September 1994 (Revised April 1995)
- Case
Banque Paribas: Paribas Derives Garantis
In March 1993, the management of Paribas Capital Markets is making a final review of the proposal to set up Paribas Derives Garantis (PDG), a special-purpose subsidiary of Compagnie Financiere de Paribas (CFP), that would guarantee derivative products offered by Banque... View Details
Keywords: Credit Derivatives and Swaps; Business Subsidiaries; Banks and Banking; Financial Services Industry
Mason, Scott P., and Kuljot Singh. "Banque Paribas: Paribas Derives Garantis." Harvard Business School Case 295-008, September 1994. (Revised April 1995.)
- 2016
- Working Paper
Options-Pricing Formula with Disaster Risk
By: Robert J. Barro and Gordon Y. Liao
A new options-pricing formula applies to far-out-of-the money put options on the overall stock market when disaster risk is the dominant force, the size distribution of disasters follows a power law, and the economy has a representative agent with Epstein-Zin utility.... View Details
Barro, Robert J., and Gordon Y. Liao. "Options-Pricing Formula with Disaster Risk." NBER Working Paper Series, No. 21888, January 2016.
- Research Summary
Overview
Professor Robertson conducts research on the history of financial markets. Her book manuscript and working papers shed light on the evolution of securities markets and the relationship between finance, governance, and society. Some of the topics she pursues include:... View Details
- Web
CSV in Practice - Institute For Strategy And Competitiveness
HBS ISC Creating Shared Value CSV Creating Shared Value CSV Explained Emerging Topics CSV in Practice Published CSV Cases CSV in Practice Creating Shared Value in Practice Not all profit is equal—an idea that has been lost in the narrow, short-term focus of financial... View Details
Best-selling and New Cases by Ben Esty
Best-Selling (MOST POPULAR) Cases:
1) Eaton: Portfolio Transformation & Cost of... View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
health care), OTC drugs (in which its Advil and Anacin were best-sellers), nutritional products (in which its infant formula preparations ranked just behind those of Abbott and Bristol-Myers in market... View Details